Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Jankowski

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomedicines|January 26, 2024
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial HypertensionKatherine Jankowski, Vineeta Jagana, Malik Bisserier, et al.
The Journal of Pastoral Care & Counseling : JPCC|September 11, 2010
2009 Spiritual Care Collaborative survey results on continuing educationMartin Montonye, Sue Wintz, William Scrivener, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Sotatercept Reverses SIN3a Deficiency-Driven PAH by Reprogramming BMPR2/TGF-β-HIF-1α Signaling PathwaysKatherine Jankowski, Anurupa Ghosh, Maria T Ochoa, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Paracrine Action of Bone Morphogenetic Protein 3 in Pulmonary Arterial HypertensionAymen Halouani, Eric Mensiah, Zaujia Athumani, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
The European Respiratory Journal|July 10, 2025
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomedicines|January 26, 2024
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial HypertensionKatherine Jankowski, Vineeta Jagana, Malik Bisserier, et al.
The Journal of Pastoral Care & Counseling : JPCC|September 11, 2010
2009 Spiritual Care Collaborative survey results on continuing educationMartin Montonye, Sue Wintz, William Scrivener, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Sotatercept Reverses SIN3a Deficiency-Driven PAH by Reprogramming BMPR2/TGF-β-HIF-1α Signaling PathwaysKatherine Jankowski, Anurupa Ghosh, Maria T Ochoa, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Paracrine Action of Bone Morphogenetic Protein 3 in Pulmonary Arterial HypertensionAymen Halouani, Eric Mensiah, Zaujia Athumani, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
The European Respiratory Journal|July 10, 2025
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Pageof 1